senCeuTics is a specialist pharmaceutical sensory evaluation company providing integrated preclinical, clinical, and formulation services to make medicines more palatable and acceptable for patients, especially children.
senCeuTics Ltd is a specialized pharmaceutical sensory evaluation company that offers a full range of integrated preclinical, clinical, and paediatric formulation services. Founded by Professor Catherine Tuleu as a spin-out from the UCL School of Pharmacy, the company focuses on Sensory Pharmaceutics, a field dedicated to researching and improving the palatability and organoleptic properties of drug products. By combining expertise in formulation science with patient-centric sensory methodologies, senCeuTics aims to ensure that medicines are acceptable to patients, particularly children, through age-appropriate dosage form development and in vitro and in vivo taste assessment.
The company provides essential consultancy and industry-leading solutions for pharmaceutical, consumer health, and nutraceutical sectors to inform patient-centric product design. By addressing issues such as bitter or aversive APIs, senCeuTics helps clients improve medication adherence and patient outcomes. Its services are designed to bridge the gap between traditional drug delivery science and clinical implementation, offering a comprehensive approach to formulation development that prioritizes the sensory experience and overall acceptability of therapeutic products.